Two psychedelics companies have announced they will be collaborating on an offering Ketamine infusions in the US and psilocybin clinical retreats internationally with a special focus on access needs for veterans.
The present agreement was signed between Revitalist Lifestyle and Wellness Ltd. RVLWF, a ketamine Clinic owners and operators and wake networka life sciences company that manufactures mushroom-derived psilocybin and medicinal mushroom products through pharmaceutical research.
Both psilocybin and ketamine have been shown to improve depression, post-traumatic stress disorder, suicidal tendencies, anxiety, and other conditions that affect the lives of many veterans. As such, the proposed retreats intend to provide quality care aligned with the necessary educational tools, research initiatives, and psychedelic medicines along with the deployment ethical approach.
The first part of the program will be an eight-day stay in the Veteran Healing Farm in North Carolina, followed by a five-day psilocybin retreat in Jamaicaa destination regularly visited by people in search of a psychedelic experience, which is currently an illegal practice on US soil.
Kathryn Walker, CEO of Revitalist commented, “The ability to offer our clients multiple psychedelic options allows us to continue to grow our business while maintaining our focus on providing ethical access to timely care.”
On behalf of Wake Network CEO Nick Murray added, “Partnering with the wonderful team at Revitalist fulfills our commitment to advance the care and research of the mental wellness community internationally through personalized psychedelic treatments.”
Revitalist recently signed one approval With Awakn Life Sciences AWKNF through which the former would use the property of the latter ketamine-assisted therapy program for the treatment of patients suffering from an alcohol use disorder.
